Age-related alteration in adrenoceptor and its physiological responses.

肾上腺素受体的年龄相关变化及其生理反应。

基本信息

  • 批准号:
    61571097
  • 负责人:
  • 金额:
    $ 1.28万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 财政年份:
    1986
  • 资助国家:
    日本
  • 起止时间:
    1986 至 1987
  • 项目状态:
    已结题

项目摘要

We investigated the relationship between the adrenoceptor signal transduction and the membrane composition in rat cerebral cortex, parotid gland and ventricular myocardium during aging. 1. Cerebral cortex: The density of specific [^3H]prazosin binding site reduced with advanced age, but the binding affinity for [^3H]prazosin did not. Norepinephrine (NE)-induced formation of [^3H]inositol phosphates increased with advanced age. The cholesterol content in membranes increased with advanced age; concomitantly, an increase of the ratio cholesterol/phspholipid was observed. The membrane viscosity as measured by using 1,6-diphenyl-1,3,5-hexatriene increased with advanced age.2. Parotid gland: NE-induced of K^+ release from the slices reduced with advanced age. The density of specific [^3H]prazosin bindng site increased with advanced age, but the binding affinity for [^3H]prazosin did not. NE-induced formation of [^3H]inositol phosphates decreased with advanced age. No difference in isoprotere … More nol (ISO)-induced decrease in K^+ release and increase in cyclic AMP content were observed at any age examined. But the binding affinity for [^3H]dihydroalprenolol binding site reduced with advanced age, and the binding affinity for [^3H]dihydroalprenolol increased. The cholesterol content in membranes decreased with advanced age; concomitantly, a decrease of the ratio cholesterol/phospholipid was observed. The membrane viscosity decreased with advanced age.3. Ventricular myocardium: The density of specific [^3H]prazosin binding site reduced with adanced age, and the binding affinity for [^3H]prazosin increased. NE-induced formation of [^3H]inositol phosphates decreased with advanced age. The cholsterol content decreased with advanced age; concomitantly, a decrease in the ratio cholesterol/phospholipid was observed. The membrane viscosity decreased with advanced age.These results suggest that the both altered cholesterol/phospholipid ratio and/or membrane viscosity during aging may account for the changes in adrenoceptor signal transduction. Less
本实验研究了大鼠大脑皮层、腮腺和心室肌细胞膜组成与肾上腺素受体信号转导的关系。1.大脑皮层:[^3H]哌唑嗪特异性结合位点的密度随年龄增长而降低,但与[^3H]哌唑嗪的结合亲和力则不随年龄增长而降低。随着年龄的增长,去甲肾上腺素(NE)诱导的[^3H]肌醇磷酸的形成增加。膜中的胆固醇含量随着年龄的增长而增加;同时,观察到胆固醇/磷脂的比率增加。用1,6-二苯基-1,3,5-己三烯测定的膜粘度随年龄的增长而增加.腮腺:NE诱导的脑片K^+释放随年龄增长而减少。[^3H]哌唑嗪特异性结合位点密度随年龄增长而增加,而结合亲和力则不随年龄增长而增加。NE诱导的[^3H]肌醇磷酸的形成随着年龄的增长而减少。异丙孕酮无差异 ...更多信息 在所观察的任何年龄,都观察到了nol(ISO)诱导的K^+释放减少和cAMP含量增加。但随着年龄的增长,[^3H]二氢烯丙洛尔结合位点的结合亲和力降低,而[^3H]二氢烯丙洛尔结合位点的结合亲和力增加。膜中的胆固醇含量随着年龄的增长而降低;同时,观察到胆固醇/磷脂比降低。膜粘度随年龄的增长而降低.心室心肌:[^3H]哌唑嗪特异性结合位点密度随年龄增长而降低,结合亲和力随年龄增长而增加。NE诱导的[^3H]肌醇磷酸的形成随着年龄的增长而减少。胆固醇含量随着年龄的增长而降低;同时,观察到胆固醇/磷脂比降低。细胞膜粘度随增龄而降低,提示衰老过程中胆固醇/磷脂比值和/或细胞膜粘度的改变可能是肾上腺素受体信号转导的变化。少

项目成果

期刊论文数量(35)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A.Miyamoto: (J.Pharm.Pharmacol.).
A.Miyamoto:(J.Pharm.Pharmacol.)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
A. Miyamoto: "Age-related altereation in _1-adrenergic singnal transduction of ratparotid gland." Submitted to Neurochem. Res.
A. Miyamoto:“大鼠腮腺_1-肾上腺素能信号转导中与年龄相关的改变。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
T.Saito: Japan.J.Pharmacol.43. 73P (1987)
T.Saito:日本.J.Pharmacol.43。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
A.Miyamoto: Japan.J.Pharmacol.43. 205P (1987)
A.Miyamoto:Japan.J.Pharmacol.43。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
宮本篤: 日薬理誌. 90. 7S (1987)
宫本敦:日本药理学杂志 90. 7S (1987)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

OHSHIKA Hideyo其他文献

OHSHIKA Hideyo的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('OHSHIKA Hideyo', 18)}}的其他基金

Phospholipase C : Diversity of isoenzyme functions and signal transduction.
磷脂酶 C:同工酶功能和信号转导的多样性。
  • 批准号:
    07457022
  • 财政年份:
    1995
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Functional Interaction Between Adrenergic Receptor Subtypes In the intracellular Signal Transduction.
细胞内信号转导中肾上腺素能受体亚型之间的功能相互作用。
  • 批准号:
    01570110
  • 财政年份:
    1989
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

Fundamental study on novel anti-tumor strategies targeting alpha2-adrenoceptor signaling
针对α2-肾上腺素受体信号传导的新型抗肿瘤策略的基础研究
  • 批准号:
    23K14098
  • 财政年份:
    2023
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Design and synthesis of novel fluorescent ligands for the Beta-3 adrenoceptor
Beta-3 肾上腺素受体新型荧光配体的设计与合成
  • 批准号:
    2745979
  • 财政年份:
    2022
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Studentship
beta2-adrenoceptor in renal cell carcinoma
肾细胞癌中的β2-肾上腺素受体
  • 批准号:
    20K18085
  • 财政年份:
    2020
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Usefulness of the vasodilator for cardiovascular adverse effects of alpha 2-adrenoceptor agonist
血管扩张剂对 α2-肾上腺素受体激动剂心血管不良反应的作用
  • 批准号:
    18K14585
  • 财政年份:
    2018
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Molecular mechanisms underlying the clinical efficacy of inhaled corticosteroid/long-acting beta2-adrenoceptor agonist combination therapies in asthma
吸入皮质类固醇/长效β2-肾上腺素受体激动剂联合疗法治疗哮喘临床疗效的分子机制
  • 批准号:
    369425
  • 财政年份:
    2017
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Operating Grants
SK Current, beta-3 adrenoceptor activation and Sex Differences in Ventricular Arrhythmogenesis
SK 电流、β3 肾上腺素受体激活和室性心律失常发生的性别差异
  • 批准号:
    10734708
  • 财政年份:
    2017
  • 资助金额:
    $ 1.28万
  • 项目类别:
Role of Gene Expression Changes in the Mechanism of Action of Long-acting Beta2-adrenoceptor Agonists in COPD
基因表达变化在长效 β2 肾上腺素受体激动剂治疗 COPD 的作用机制中的作用
  • 批准号:
    358286
  • 财政年份:
    2016
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Operating Grants
Molecular mechanisms underlying the enhanced efficacy of inhaled corticosteroid/long-acting beta2-adrenoceptor agonist combinations used in asthma
吸入皮质类固醇/长效β2-肾上腺素受体激动剂组合增强哮喘疗效的分子机制
  • 批准号:
    366550
  • 财政年份:
    2016
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Operating Grants
Basic and clinical studies on the renal effects of the alpha 2-adrenoceptor agonist
α2-肾上腺素受体激动剂肾脏影响的基础和临床研究
  • 批准号:
    15K18794
  • 财政年份:
    2015
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Pharmacological study on increased bone formation by alpha1-adrenoceptor signaling in bone metabolism.
骨代谢中α1-肾上腺素受体信号增加骨形成的药理学研究。
  • 批准号:
    26462827
  • 财政年份:
    2014
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了